Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Irritable Bowel Syndrome With Constipation · Chronic Constipation · IRWD

IRONWOOD PHARMACEUTICALS

IRONWOOD PHARMACEUTICALS INC

IRONWOOD PHARMACEUTICALS trial registry — 41 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
100 Summer Street, Boston, MA 02110, US HQ
1998 Founded
262 Employees
Public company Type
IRWD · NYSE Ticker
Company details
Status
Public
HQ
100 Summer Street, Boston, MA 02110, US
Founded
1998
Employees
262
Programs
33
Drugs
11
Patents
45
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

IRONWOOD PHARMACEUTICALS clinical trials

Registry index of 41 ClinicalTrials.gov studies linked to IRONWOOD PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.

IRONWOOD PHARMACEUTICALS trial registry — 41 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for IRONWOOD PHARMACEUTICALS.

  1. LIN-MD-66 — Phase 3

    Clinical update

  2. Placebo for Linaclotide — Phase 3

    Clinical update

  3. Linaclotide or Matching Placebo — Phase 3

    Clinical update

  4. Linaclotide Dose A — Phase 2

    Clinical update

  5. Linaclotide Acetate — Phase 2

    Clinical update

  6. linaclotide acetate — Phase 2

    Clinical update

  7. Linaclotide 290 micrograms — Phase 3

    Clinical update

  8. Linaclotide 290 micrograms — Phase 3

    Clinical update

Trial registry

41 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.